Fuller & Thaler Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Fuller & Thaler Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$320K	Buy	+91,081	New	+$373K	﹤0.01%	472

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fuller & Thaler Asset Management's IRWD Position: Q1 2026 in Review

Fuller & Thaler Asset Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 91,081 shares worth $320K. The stake represents ﹤0.01% of the portfolio and ranks #472 among its holdings.

226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Fuller & Thaler Asset Management held 91,081 shares of Ironwood Pharmaceuticals worth $320K as of Q1 2026.
Ironwood Pharmaceuticals was a new Fuller & Thaler Asset Management position in Q1 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Fuller & Thaler Asset Management's portfolio in Q1 2026, its #472 holding.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.